Patents by Inventor Ana Negrete-Raymond

Ana Negrete-Raymond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240018464
    Abstract: Less-than-diploid I. orientalis cells are produced. The cells have at least one unpaired chromosome and may be haploid, i.e., are missing one member of each pair of chromosomes that are present in the wild-type strains. The less-than-diploid cells are useful fermentation strains, performing similarly to diploid strains that are otherwise similarly engineered. The less-than-diploid strains can be mated to produce diploids, which themselves are useful fermentation strains. The less-than-diploid strains are also useful as host strains for producing further genetically modified strains that can be less-than-diploid or mated to produce diploids.
    Type: Application
    Filed: June 15, 2023
    Publication date: January 18, 2024
    Applicant: CARGILL, INCORPORATED
    Inventors: Kenneth R. FINLEY, Holly JESSEN, Erin Kathleen MARASCO, Thomas William MCCMULLIN, Ana NEGRETE-RAYMOND, Amit VAS
  • Patent number: 11718820
    Abstract: Less-than-diploid I. orientalis cells are produced. The cells have at least one unpaired chromosome and may be haploid, i.e., are missing one member of each pair of chromosomes that are present in the wild-type strains. The less-than-diploid cells are useful fermentation strains, performing similarly to diploid strains that are otherwise similarly engineered. The less-than-diploid strains can be mated to produce diploids, which themselves are useful fermentation strains. The less-than-diploid strains are also useful as host strains for producing further genetically modified strains that can be less-than-diploid or mated to produce diploids.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: August 8, 2023
    Assignee: CARGILL, INCORPORATED
    Inventors: Kenneth R. Finley, Holly Jessen, Erin Kathleen Marasco, Thomas William McMullin, Ana Negrete-Raymond, Amit Vas
  • Patent number: 11591620
    Abstract: A system for editing of a target sequence at a locus of a host cell is disclosed. The system has a nucleic acid molecule comprising a nucleic acid segment comprising a targeting RNA sequence and an RNA segment that binds a protein. The system also has a nucleic acid molecule comprising a nucleic acid segment encoding a polypeptide with endonuclease activity fused to a protein that binds the RNA segment. The system also comprises a double stranded DNA molecule comprising DNA comprising at least one nucleotide sequence that is capable of binding to the target sequence at the locus.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: February 28, 2023
    Assignee: CARGILL, INCORPORATED
    Inventors: Kenneth R. Finley, Briana Kozlowicz, Ana Negrete-Raymond, Gregory M. Poynter, Amit Vas
  • Publication number: 20220403425
    Abstract: Genes encoding mutant 3-ketoacyl-CoA synthases are introduced into host cells. Certain of the mutants enhance the production of shorter-chain fatty acids and derivatives by the cell than do the wild-type (unmutated) enzymes. In other cases, the chain length is not significantly affected, but productivity is enhanced. In specific cases, both a shift toward lower chain length and higher productivity is seen. Cells producing the mutant 3-ketoacyl-CoA synthases are especially suitable for producing C6-C10 fatty acids and derivatives.
    Type: Application
    Filed: May 2, 2022
    Publication date: December 22, 2022
    Applicant: CARGILL, INCORPORATED
    Inventors: Hans H. LIAO, Catherine Bradshaw POOR, Travis Robert WOLTER, Michael Tai Man LOUIE, Erin Kathleen MARASCO, Ana NEGRETE-RAYMOND
  • Publication number: 20220177926
    Abstract: A system for editing of a target sequence at a locus of a host cell is disclosed. The system has a nucleic acid molecule comprising a nucleic acid segment comprising a targeting RNA sequence and an RNA segment that binds a protein. The system also has a nucleic acid molecule comprising a nucleic acid segment encoding a polypeptide with endonuclease activity fused to a protein that binds the RNA segment. The system also comprises a double stranded DNA molecule comprising DNA comprising at least one nucleotide sequence that is capable of binding to the target sequence at the locus.
    Type: Application
    Filed: May 18, 2018
    Publication date: June 9, 2022
    Applicant: CARGILL, INCORPORATED
    Inventors: Kenneth R. FINLEY, Briana KOZLOWICZ, Ana NEGRETE-RAYMOND, Gregory M. POYNTER, Amit VAS
  • Patent number: 11345938
    Abstract: Genes encoding mutant 3-ketoacyl-CoA synthases are introduced into host cells. Certain of the mutants enhance the production of shorter-chain fatty acids and derivatives by the cell than do the wild-type (unmutated) enzymes. In other cases, the chain length is not significantly affected, but productivity is enhanced. In specific cases, both a shift toward lower chain length and higher productivity is seen. Cells producing the mutant 3-ketoacyl-CoA synthases are especially suitable for producing C6-C10 fatty acids and derivatives.
    Type: Grant
    Filed: February 1, 2018
    Date of Patent: May 31, 2022
    Assignee: CARGILL, INCORPORATED
    Inventors: Hans H. Liao, Catherine Bradshaw Poor, Travis Robert Wolter, Michael Tai Man Louie, Erin Kathleen Marasco, Ana Negrete-Raymond
  • Publication number: 20200308613
    Abstract: A recombinant cell for producing a fatty acid ester. The recombinant cell is genetically engineered to produce a reduction in free fatty acids compared to a cell that has not been similarly genetically engineered. Methods for producing fatty acid esters while decreasing free fatty acid production are also described.
    Type: Application
    Filed: April 1, 2020
    Publication date: October 1, 2020
    Applicant: CARGILL, INCORPORATED
    Inventors: Michael Tai Man LOUIE, Ana NEGRETE-RAYMOND, Travis Robert WOLTER
  • Publication number: 20200270644
    Abstract: Genetically modified yeast having a heterologous sugar transporter that is capable of transporting a non-glucose sugar such as maltulose, are described. The heterologous sugar transporter can be a protein according to, or that has similarity to, SEQ ID NO:44. Fermentation methods using enzymatically treated starch where the yeast are able to consume the non-glucose sugars, are also described. The engineered yeast can be useful for producing desired bioproducts such as high ethanol, with low amounts of residual sugars in the medium.
    Type: Application
    Filed: December 16, 2016
    Publication date: August 27, 2020
    Inventors: CHRISTOPHER K. MILLER, Ana Negrete-Raymond, Brian J. Rush, Amit Vas, Jon Veldhouse
  • Patent number: 10724023
    Abstract: The invention is directed to non-natural yeast able to secrete significant amounts of glucoamylase into a fermentation media. The glucoamylase can promote degradation of starch material generating glucose for fermentation to a desired bioproduct, such as ethanol. The glucoamylase can be provided in the form of a glucoamylase fusion protein having a S. cerevisiae mating factor alpha 2 (Sc MF?2) or repressible acid phosphatase (Sc PHO5) secretion signal.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: July 28, 2020
    Assignee: CARGILL, INCORPORATED
    Inventors: Christopher K. Miller, Ana Negrete-Raymond, Jonathan Dwight Veldhouse, Amit Vas
  • Publication number: 20200172855
    Abstract: Less-than-diploid I. orientalis cells are produced. The cells have at least one unpaired chromosome and may be haploid, i.e., are missing one member of each pair of chromosomes that are present in the wild-type strains. The less-than-diploid cells are useful fermentation strains, performing similarly to diploid strains that are otherwise similarly engineered. The less-than-diploid strains can be mated to produce diploids, which themselves are useful fermentation strains. The less-than-diploid strains are also useful as host strains for producing further genetically modified strains that can be less-than-diploid or mated to produce diploids.
    Type: Application
    Filed: August 2, 2018
    Publication date: June 4, 2020
    Applicant: CARGILL, INCORPORATED
    Inventors: Kenneth R. FINLEY, Holly JESSEN, Erin Kathleen MARASCO, Thomas William MCCMULLIN, Ana NEGRETE-RAYMOND, Amit VAS
  • Publication number: 20200048623
    Abstract: The invention is directed to non-natural yeast able to secrete significant amounts of glucoamylase into a fermentation media. The glucoamylase can promote degradation of starch material generating glucose for fermentation to a desired bioproduct, such as ethanol. The glucoamylase can be provided in the form of a glucoamylase fusion protein having a S. cerevisiae mating factor alpha 2 (Sc MF?2) or repressible acid phosphatase (Sc PHO5) secretion signal.
    Type: Application
    Filed: July 15, 2019
    Publication date: February 13, 2020
    Applicant: CARGILL, INCORPORATED
    Inventors: Christopher K. MILLER, Ana NEGRETE-RAYMOND, Jon VELDHOUSE, Amit VAS
  • Publication number: 20190376071
    Abstract: Genetically engineered yeast with a heterologous glucoamylase and fermentation methods are described. The engineered yeast can have multiple exogenous nucleic acid sequences which each have a different sequence, but that encode the same or a similar glucoamylase protein that is heterologous to the yeast. The engineered yeast exhibit desirable bioproduct production profiles during a fermentation process. A fermentation medium with a starch material can be fermented with the engineered yeast to provide high ethanol titers, low glycerol titers, or both.
    Type: Application
    Filed: June 12, 2019
    Publication date: December 12, 2019
    Applicant: CARGILL, INCORPORATED
    Inventors: Christopher K. Miller, Ana Negrete-Raymond, Jon Veldhouse, Amit Vas
  • Publication number: 20190360010
    Abstract: Genes encoding mutant 3-ketoacyl-CoA synthases are introduced into host cells. Certain of the mutants enhance the production of shorter-chain fatty acids and derivatives by the cell than do the wild-type (unmutated) enzymes. In other cases, the chain length is not significantly affected, but productivity is enhanced. In specific cases, both a shift toward lower chain length and higher productivity is seen. Cells producing the mutant 3-ketoacyl-CoA synthases are especially suitable for producing C6-C10 fatty acids and derivatives.
    Type: Application
    Filed: February 1, 2018
    Publication date: November 28, 2019
    Applicant: GARGILL, INCORPORATED
    Inventors: Hans H. LIAO, Catherine Bradshaw POOR, Travis Robert WOLTER, Michael Tai Man LOUIE, Erin Kathleen MARASCO, Ana NEGRETE-RAYMOND
  • Patent number: 10364421
    Abstract: The invention is directed to non-natural yeast able to secrete significant amounts of glucoamylase into a fermentation media. The glucoamylase can promote degradation of starch material generating glucose for fermentation to a desired bioproduct, such as ethanol. The glucoamylase can be provided in the form of a glucoamylase fusion protein having a S. cerevisiae mating factor alpha 2 (Sc MF?2) or repressible acid phosphatase (Sc PHO5) secretion signal.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: July 30, 2019
    Assignee: CARGILL, INCORPORATED
    Inventors: Christopher K. Miller, Ana Negrete-Raymond, Jon Veldhouse, Amit Vas
  • Patent number: 10344288
    Abstract: Genetically engineered yeast with a heterologous glucoamylase and fermentation methods are described. The engineered yeast can have multiple exogenous nucleic acid sequences which each have a different sequence, but that encode the same or a similar glucoamylase protein that is heterologous to the yeast. The engineered yeast exhibit desirable bioproduct production profiles during a fermentation process. A fermentation medium with a starch material can be fermented with the engineered yeast to provide high ethanol titers, low glycerol titers, or both.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: July 9, 2019
    Assignee: CARGILL, INCORPORATED
    Inventors: Christopher K. Miller, Ana Negrete-Raymond, Jon Veldhouse, Amit Vas
  • Publication number: 20180094269
    Abstract: Genetically engineered yeast with a heterologous glucoamylase and fermentation methods are described. The engineered yeast can have multiple exogenous nucleic acid sequences which each have a different sequence, but that encode the same or a similar glucoamylase protein that is heterologous to the yeast. The engineered yeast exhibit desirable bioproduct production profiles during a fermentation process. A fermentation medium with a starch material can be fermented with the engineered yeast to provide high ethanol titers, low glycerol titers, or both.
    Type: Application
    Filed: March 25, 2016
    Publication date: April 5, 2018
    Inventors: Christopher K. MILLER, Ana NEGRETE-RAYMOND, Jon VELDHOUSE, Amil VAS
  • Publication number: 20180080014
    Abstract: The invention is directed to non-natural yeast able to secrete significant amounts of glucoamylase into a fermentation media. The glucoamylase can promote degradation of starch material generating glucose for fermentation to a desired bioproduct, such as ethanol. The glucoamylase can be provided in the form of a glucoamylase fusion protein having a S. cerevisiae mating factor alpha 2 (Sc MF?2) or repressible acid phosphatase (Sc PHO5) secretion signal.
    Type: Application
    Filed: February 5, 2016
    Publication date: March 22, 2018
    Inventors: Christopher K. Miller, Ana NEGRETE-RAYMOND, Jon VELDHOUSE, Amit VAS
  • Patent number: 9862975
    Abstract: The present application discloses the identification of the novel K. marxianus xylose transporter genes KHT105 and RAG4, as well as the identification of a novel set of I. orientalis pentose phosphate pathway genes The present application further discloses a series of genetically modified yeast cells comprising various combinations of arabinose fermentation pathways, xylose fermentation pathways, pentose phosphate pathways, and/or xylose transporter genes, and methods of culturing these cells to produce ethanol in fermentation media containing xylose.
    Type: Grant
    Filed: September 18, 2015
    Date of Patent: January 9, 2018
    Assignee: CARGILL, INCORPORATED
    Inventors: Holly J. Jessen, Jian Yi, Joshua Lundorff, Hans Liao, Ana Negrete-Raymond, Pirkko Suominen, Aristos Aristidou
  • Patent number: 9845484
    Abstract: Provided herein are recombinant yeast cells having an active 3-Hydroxypropionic Acid (3-HP) pathway and further comprising a heterologous polynucleotide encoding an aspartate 1-decarboxylase (ADC) of the Class Insecta, Bivalvia, Branchioporia, Gastropoda, or Leptocardii. Also described are methods of using the recombinant yeast cells to produce 3-HP and acrylic acid.
    Type: Grant
    Filed: July 31, 2014
    Date of Patent: December 19, 2017
    Assignee: NOVOZYMES A/S
    Inventors: Michelle Barnhart, Ana Negrete-Raymond, Janice Frias, Gui Barbier, Michael Catlett
  • Publication number: 20160168600
    Abstract: Provided herein are recombinant yeast cells having an active 3-Hydroxypropionic Acid (3-HP) pathway and further comprising a heterologous polynucleotide encoding an aspartate 1-decarboxylase (ADC) of the Class Insecta, Bivalvia, Branchioporia, Gastropoda, or Leptocardii. Also described are methods of using the recombinant yeast cells to produce 3-HP and acrylic acid.
    Type: Application
    Filed: July 31, 2014
    Publication date: June 16, 2016
    Applicant: NOVOZYMES A/S
    Inventors: Michelle Barnhart, Ana Negrete-Raymond, Janice Frias, Gui Barbier, Michael Catlett